FDA updates remote monitoring guidance, approves generic intubation drugs
The Food and Drug Administration Wednesday updated its on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.
FDA said the document expands on devices, including gaseous-phase carbon-dioxide gas analyzers, which include capnographs and devices with capnography features.
FDA yesterday also approved two generic injectable drugs to facilitate tracheal intubation: and . These drugs are intended to help meet the demand for skeletal muscle relaxation during surgery or mechanical ventilation during the COVID-19 emergency.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…